SEC Form 4 · accession 0001144204-16-133272
CALADRIUS BIOSCIENCES, INC. · CLBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Douglas W Losordo
Officer — See Remarks
Period of report
Oct 25, 2016
Accepted (ET)
Nov 10, 2016 · 4:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000320017
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 25, 2016 | F | 176 | $4.12 | D | 14,851 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 4,271 shares of unvested restricted stock.
Remarks
Senior Vice President, Clinical, Medical and Regulatory Affairs and Chief Medical Officer. All share numbers and per share prices disclosed in this Form 4 reflect the Issuer's common stock on October 25, 2016.